FIT-001
Kura Oncology, Inc.
Kura Oncology, Inc.
7 Hills Pharma, LLC
Memorial Sloan Kettering Cancer Center
KaliVir Immunotherapeutics
Actuate Therapeutics Inc.
Xencor, Inc.
Nuvectis Pharma, Inc.
Pfizer
Tizona Therapeutics, Inc
Essen Biotech
Takeda
Kidney Cancer Research Bureau
Second Life Therapeutics
Novartis
University of Cambridge
Degron Therapeutics Co.
AstraZeneca
Dana-Farber Cancer Institute
Coherus Oncology, Inc.
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
National Institutes of Health Clinical Center (CC)
A2 Biotherapeutics Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Genentech, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
DEKA Biosciences
Columbia University
Elevation Oncology
Centre Georges Francois Leclerc
Rutgers, The State University of New Jersey
Nimbus Therapeutics
Astellas Pharma Inc
Astellas Pharma Inc
Dana-Farber Cancer Institute
Inhibrx Biosciences, Inc
Hospices Civils de Lyon
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Second Affiliated Hospital of Guangzhou Medical University
Washington University School of Medicine
Cedars-Sinai Medical Center
Celldex Therapeutics
AO GENERIUM
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Corvus Pharmaceuticals, Inc.